Literature DB >> 19778475

Effects of ovulation induction agents on ovarian surface epithelium in rats.

Zeynep Ozcan1, Husnu Celik, Bilgin Gurates, Hanifi Ibrahim Ozercan, Fethi Hanay, Mehmet Nalbant, Zeynep Dogan.   

Abstract

The aim of this study was to examine the effects of ovulation induction agents on the ovarian surface epithelium in rats. Sixty adult females were randomly divided into six groups, each containing 10 rats. In four of these groups ovulation induction was applied with six cycles of clomiphene citrate, human menopausal gonadotrophin (HMG), recombinant FSH (rFSH) or human chorionic gonadotrophin (HCG), respectively, followed by unilateral oophorectomy, and another six cycles of the same treatment. After a total of 12 cycles of ovulation induction, the remaining ovary was taken out and the alterations in ovarian surface epithelium were examined. No malignancies were observed on the ovarian surface epithelium of the rats that were given clomiphene citrate, rFSH or HMG as ovulation induction agents, while identification rates of histopathological parameters constituting epithelial dysplasia were found to be significant (P < 0.05). There was no significant dysplasia in the epithelium of the group which was given HCG only, relative to control groups. The findings suggest that the ovulation induction agents except for HCG bring about dysplasia in the ovarian surface epithelium. It is not clear whether these dysplasias are precursory lesions of ovarian malignancies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19778475     DOI: 10.1016/s1472-6483(10)60164-2

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  6 in total

1.  Reversal of tubo-ovarian atypical epithelial patterns after cessation of ovarian stimulation by letrozole.

Authors:  Ahmed A M Abdel-Hamid; Yaser Mesbah; Mona F M Soliman
Journal:  Int J Exp Pathol       Date:  2016-09-01       Impact factor: 1.925

2.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

Review 3.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2013-08-13

4.  Is There a Relationship between Ovarian Epithelial Dysplasia and Infertility?

Authors:  Gautier Chene; Frédérique Penault-Llorca; Anne Tardieu; Anne Cayre; Nicole Lagarde; Patricia Jaffeux; Bruno Aublet-Cuvelier; Pierre Dechelotte; Bertrand Felloni; Jean-Luc Pouly; Jacques Dauplat
Journal:  Obstet Gynecol Int       Date:  2012-02-09

5.  Rescue IVM of Denuded GV- and MI-Stage Oocytes of Premenopausal Rats with Oncostatin M, Insulin-like Growth Factor I, and Growth Hormone.

Authors:  Yesim Akdemir; Yaprak Donmez Cakil; Belgin Selam; Mustafa Erinc Sitar; Mehmet Cincik
Journal:  Life (Basel)       Date:  2022-08-16

6.  Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen.

Authors:  G Chene; N Radosevic-Robin; A S Tardieu; A Cayre; I Raoelfils; P Dechelotte; J Dauplat; F Penault Llorca
Journal:  Eur J Histochem       Date:  2014-04-15       Impact factor: 3.188

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.